LEO Pharma | pharmaphorum

Friday 2 May 2025

Channels

Content type

Categories

Categories

Sort by

Order

LEO Pharma

News

Chronic skin diseases - psoriasis, eczema, dermatitis.

Leo Pharma announces positive results for hand eczema study

In good news for patients living with chronic hand eczema (CHE), Leo Pharma – a company working to advance medical dermatology treatments – has unveiled positive topline results for i

News

LEO Pharma's Adtralza approved by MHRA, EC for adolescent at...

The Medicines and Healthcare products Regulatory Agency (MHRA) and the European Commission (EC) have

News

Human skin macro photo

Leo puts target on Dupixent in US as FDA clears tralokinumab

Sanofi and Regeneron have another challenger to their big-selling drug Dupixent for atopic dermatitis, now that the FDA has approved Leo Pharma's rival antibody tralokinumab.

Views & Analysis

LEO Pharmas new R&D lead on driving agility in drug development

LEO Pharma’s new R&D lead on driving agility in drug develop...

After 27 years at Bayer, Jörg Möller has moved to LEO Pharma as the company’s EVP, global research and development.

Views & Analysis

Research and Development

Deep Dive: Research and Development

Pharma’s historic R&D efforts have given us some light at the end of the COVID tunnel.

Sales & Marketing

pharmaphorum_podcast-Episode-24

Gitte Aabo on telemedicine and GN Hearing: the pharmaphorum ...

Joining the pharmaphorum podcast for episode 24 is Gitte Aabo, who last year moved to hearing aid technology firm GN Hearing as CEO.